As such targeting of CXCR4 expression on BMICs may be a potential option for limiting BM formation in some cancers, with a focus on expression modulation as studies have shown antagonism of CXCR4 may enhance a tumor cell’s metastatic ability [75]. This evidence concerns the gene CXCR4 and cancer.